| abstract |
The invention relates to an extended release oral pharmaceutical composition comprising a core, wherein the core comprises apremilast or pharmaceutically acceptable salts, ester, solvates, polymorphs thereof, at least one extended release polymer and one or more pharmaceutically acceptable excipients, wherein the core is optionally coated with a film coating composition. The composition of the invention can be used for the treatment of psoriasis, psoriatic arthritis. |